Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 10 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 11156612

    Methods of determining levels of cleaved and/or intact kininogen

    Takeda Pharmaceutical Company Limited · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  2. US 11136350

    Method to produce an immunoglobulin preparation with improved yield

    Takeda Pharmaceutical Company Limited · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted
  3. US 11130777

    Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-L-ribofuranosyl)-1H-benzimidazole

    Takeda Pharmaceutical Company Limited · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted
  4. US 11129828

    Pyridazinone compounds and their use as DAAO inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted
  5. US 11124787

    ADAMTS13-containing compositions having thrombolytic activity

    Takeda Pharmaceutical Company Limited · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted
  6. US 11116823

    Treatment of α-galactosidase a deficiency

    Takeda Pharmaceutical Company Limited · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  7. US 11084884

    Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema

    Takeda Pharmaceutical Company Limited · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted
  8. US 11066362

    Method for producing pyrrole compound

    Takeda Pharmaceutical Company Limited · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted
  9. US 11059906

    Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scleroderma

    Takeda Pharmaceutical Company Limited · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  10. US 11059780

    Substituted pyrrolidine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  11. US 11053262

    Heterocyclic amide compounds having RORyT inhibitory action

    Takeda Pharmaceutical Company Limited · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  12. US 11045457

    Piperidinyl-3-(aryloxy)propanamides and propanoates

    Takeda Pharmaceutical Company Limited · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  13. US 11046785

    Compositions and methods for treatment of diabetic macular edema

    Takeda Pharmaceutical Company Limited · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  14. US 11040109

    Blood coagulation protein conjugates

    Takeda Pharmaceutical Company Limited · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  15. US 11033550

    Medicament

    Takeda Pharmaceutical Company Limited · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  16. US 11034700

    Substituted pyrrolidine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  17. US 11033551

    Methods of treating uterine fibroids

    Takeda Pharmaceutical Company Limited · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  18. US 11028048

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  19. US 11020458

    Factor VIII polymer conjugates

    Takeda Pharmaceutical Company Limited · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  20. US 11020461

    Methods and compositions for CNS delivery of arylsulfatase A

    Takeda Pharmaceutical Company Limited · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  21. US 11000561

    Adeno-associated virus purification methods

    Takeda Pharmaceutical Company Limited · Granted May 11, 2021 · Expires May 6, 2041

    granted
  22. US 11001613

    TFPI inhibitors and methods of use

    Takeda Pharmaceutical Company Limited · Granted May 11, 2021 · Expires May 6, 2041

    granted
  23. US 10981934

    Fused heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  24. US 10980825

    Cyclic dinucleotide

    Takeda Pharmaceutical Company Limited · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted